-
公开(公告)号:US07700641B2
公开(公告)日:2010-04-20
申请号:US11402310
申请日:2006-04-11
申请人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
发明人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
IPC分类号: A61K31/407 , C07D491/107
CPC分类号: C07D491/10
摘要: This invention is directed to spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of preparing and using the compounds are also disclosed.
摘要翻译: 本发明涉及式(I)的螺 - 羟吲哚化合物:其中k,j,Q,R1,R2a,R2b,R2c,R2d,R3a,R3b,R3c和R3d如本文所定义,作为立体异构体, 其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药,其可用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。 还公开了包含化合物的药物组合物以及制备和使用化合物的方法。
-
公开(公告)号:US20100173967A1
公开(公告)日:2010-07-08
申请号:US12445264
申请日:2007-10-12
申请人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Duanjie Hou , Shifeng Liu , Mehran Seid Bagherzadeh , Serguei Sviridov , Shaoyi Sun , Jianyu Sun , Nagasree Chakka , Tom Hsieh , Vandna Raina
发明人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Duanjie Hou , Shifeng Liu , Mehran Seid Bagherzadeh , Serguei Sviridov , Shaoyi Sun , Jianyu Sun , Nagasree Chakka , Tom Hsieh , Vandna Raina
IPC分类号: A61K31/404 , A61P9/10 , A61P17/04 , A61P35/00
CPC分类号: A61K31/407 , A61K31/437
摘要: This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment and/or prevention of hypercholesterolemia, benign prostatic hyperplasia, pruritis and cancer.
摘要翻译: 本发明涉及使用式(I)的螺 - 羟吲哚化合物的方法:其中k,j,Q,R1,R2a,R2b,R2c,R2d,R3a,R3b,R3c和R3d如本文所定义, 立体异构体,对映异构体,互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药,用于治疗和/或预防高胆固醇血症,良性前列腺增生,瘙痒症和癌症。
-
公开(公告)号:US20100125072A1
公开(公告)日:2010-05-20
申请号:US12650196
申请日:2009-12-30
申请人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
发明人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
IPC分类号: A61K31/5377 , C07D491/10 , A61K31/407 , A61K31/4439 , A61K31/506
CPC分类号: C07D491/10
摘要: This invention is directed to spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of preparing and using the compounds are also disclosed.
-
公开(公告)号:US08466188B2
公开(公告)日:2013-06-18
申请号:US12445264
申请日:2007-10-12
申请人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Duanjie Hou , Shifeng Liu , Mehran Seid Bagherzadeh , Serguei Sviridov , Shaoyi Sun , Jianyu Sun , Nagasree Chakka , Tom Hsieh , Vandna Raina
发明人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Duanjie Hou , Shifeng Liu , Mehran Seid Bagherzadeh , Serguei Sviridov , Shaoyi Sun , Jianyu Sun , Nagasree Chakka , Tom Hsieh , Vandna Raina
IPC分类号: A61K31/40 , A61K31/5377
CPC分类号: A61K31/407 , A61K31/437
摘要: This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment and/or prevention of hypercholesterolemia, benign prostatic hyperplasia, pruritis and cancer.
摘要翻译: 本发明涉及使用式(I)的螺 - 羟吲哚化合物的方法:其中k,j,Q,R1,R2a,R2b,R2c,R2d,R3a,R3b,R3c和R3d如本文所定义, 立体异构体,对映异构体,互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药,用于治疗和/或预防高胆固醇血症,良性前列腺增生,瘙痒症和癌症。
-
公开(公告)号:US20080103151A9
公开(公告)日:2008-05-01
申请号:US11407859
申请日:2006-04-20
申请人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Serguei Sviridov
发明人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Serguei Sviridov
IPC分类号: A61K31/519 , A61K31/498 , A61K31/4745 , A61K31/4162 , A61K31/407 , C07D487/02 , C07D498/02
CPC分类号: C07D405/04 , C07D471/04 , C07D487/04 , C07D495/04
摘要: This invention is directed to heterocyclic compounds that are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of using the compounds are also disclosed.
摘要翻译: 本发明涉及可用于治疗和/或预防钠通道介导的疾病或病症如疼痛的杂环化合物。 还公开了包含该化合物的药物组合物和使用该化合物的方法。
-
公开(公告)号:US20070105820A1
公开(公告)日:2007-05-10
申请号:US11408269
申请日:2006-04-20
申请人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
发明人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
IPC分类号: A61K31/404 , A61K31/675 , C07D403/02 , C07F9/572
CPC分类号: C07D409/06 , C07D209/34 , C07D209/38 , C07D209/40 , C07D401/04 , C07D401/06 , C07D403/04 , C07D403/06 , C07D403/10 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/14 , C07D413/04 , C07D417/04
摘要: This invention is directed to oxindole compounds that are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of using the compounds are also disclosed.
摘要翻译: 本发明涉及可用于治疗和/或预防钠通道介导的疾病或病症(例如疼痛)的羟吲哚化合物。 还公开了包含该化合物的药物组合物和使用该化合物的方法。
-
公开(公告)号:US20060258659A1
公开(公告)日:2006-11-16
申请号:US11407859
申请日:2006-04-20
申请人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Serguei Sviridov
发明人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Serguei Sviridov
IPC分类号: A61K31/519 , A61K31/498 , A61K31/4745 , A61K31/4162 , A61K31/407 , C07D487/02 , C07D498/02
CPC分类号: C07D405/04 , C07D471/04 , C07D487/04 , C07D495/04
摘要: This invention is directed to heterocyclic compounds that are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of using the compounds are also disclosed.
摘要翻译: 本发明涉及可用于治疗和/或预防钠通道介导的疾病或病症如疼痛的杂环化合物。 还公开了包含该化合物的药物组合物和使用该化合物的方法。
-
公开(公告)号:US08106087B2
公开(公告)日:2012-01-31
申请号:US12650196
申请日:2009-12-30
申请人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
发明人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
IPC分类号: A61K31/407 , A61K31/5377
CPC分类号: C07D491/10
摘要: This invention is directed to spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of preparing and using the compounds are also disclosed.
摘要翻译: 本发明涉及式(I)的螺 - 羟吲哚化合物:其中k,j,Q,R1,R2a,R2b,R2c,R2d,R3a,R3b,R3c和R3d如本文所定义,作为立体异构体, 其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药,其可用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。 还公开了包含化合物的药物组合物以及制备和使用化合物的方法。
-
公开(公告)号:US20110172282A9
公开(公告)日:2011-07-14
申请号:US12445264
申请日:2007-10-12
申请人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Duanjie Hou , Shifeng Liu , Mehran Seid Bagherzadeh , Serguei Sviridov , Shaoyi Sun , Jianyu Sun , Nagasree Chakka , Tom Hsieh , Vandna Raina
发明人: Mikhail Chafeev , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Rajender Kamboj , Duanjie Hou , Shifeng Liu , Mehran Seid Bagherzadeh , Serguei Sviridov , Shaoyi Sun , Jianyu Sun , Nagasree Chakka , Tom Hsieh , Vandna Raina
IPC分类号: A61K31/404 , A61P9/10 , A61P17/04 , A61P35/00
CPC分类号: A61K31/407 , A61K31/437
摘要: This invention is directed to methods of using spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment and/or prevention of hypercholesterolemia, benign prostatic hyperplasia, pruritis and cancer.
摘要翻译: 本发明涉及使用式(I)的螺 - 羟吲哚化合物的方法:其中k,j,Q,R1,R2a,R2b,R2c,R2d,R3a,R3b,R3c和R3d如本文所定义, 立体异构体,对映异构体,互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药,用于治疗和/或预防高胆固醇血症,良性前列腺增生,瘙痒症和癌症。
-
10.
公开(公告)号:US20100130487A1
公开(公告)日:2010-05-27
申请号:US12650218
申请日:2009-12-30
申请人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
发明人: Mikhail Chafeev , Nagasree Chakka , Sultan Chowdhury , Robert Fraser , Jianmin Fu , Duanjie Hou , Tom Hsieh , Rajender Kamboj , Shifeng Liu , Vandna Raina , Mehran Seid Bagherzadeh , Jianyu Sun , Shaoyi Sun , Serguei Sviridov
IPC分类号: A61K31/407 , C07D491/20 , A61K31/4439 , A61K31/506 , A61K31/5377 , A61P25/24 , A61P9/00 , A61P11/00 , A61P25/00
CPC分类号: C07D491/10
摘要: This invention is directed to spiro-oxindole compounds of formula (I): wherein k, j, Q, R1, R2a, R2b, R2c, R2d, R3a, R3b, R3c, and R3d are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. Pharmaceutical compositions comprising the compounds and methods of preparing and using the compounds are also disclosed.
摘要翻译: 本发明涉及式(I)的螺 - 羟吲哚化合物:其中k,j,Q,R1,R2a,R2b,R2c,R2d,R3a,R3b,R3c和R3d如本文所定义,作为立体异构体, 其互变异构体或其混合物; 或其药学上可接受的盐,溶剂合物或前药,其可用于治疗和/或预防钠通道介导的疾病或病症,例如疼痛。 还公开了包含化合物的药物组合物以及制备和使用化合物的方法。
-
-
-
-
-
-
-
-
-